Kewajiban jangka dawa perusahaan: Novartis Corporation (NVS)

Novartis AG (NVS) actively engages external contractors for molecule synthesis and logistics. The Swiss behemoth is renowned for its impeccable quality and breakthrough biomedical developments. Transparent management and a scientific approach ensure high trust in the brand. The organization's long-term credits and loans are shown on this chart, where the 40.29 mark characterizes this parameter, allowing for an assessment of the efficiency of debt load management.

This metric is calculated as the aggregate of all loan and bond obligations with a maturity exceeding one year. This metric determines the long-term credit load, allowing for an assessment of the financial stability of the capital structure. The stable cash flow of Novartis AG (NVS) from its patent portfolio minimizes the risks associated with servicing such loans. Monitoring the issuer's long-term liabilities confirms the company's ability to maintain its market positions without a critical increase in debt.